David A. Siegel Cassava Sciences Inc Put Options Transaction History
Two Sigma Advisers, LP
- $46.1 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SAVA
# of Institutions
131Shares Held
14.2MCall Options Held
962KPut Options Held
864K-
Black Rock Inc. New York, NY3.22MShares$11.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.17MShares$7.75 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY790KShares$2.82 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY613KShares$2.19 Million0.0% of portfolio
-
Two Sigma Investments, LP New York, NY527KShares$1.88 Million0.0% of portfolio
About CASSAVA SCIENCES INC
- Ticker SAVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,097,900
- Market Cap $143M
- Description
- Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...